
ShockWave Medical SWAV
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Accounts Payables 2011-2026 | SWAV
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.87 M | 6.72 M | 3.52 M | 1.47 M | 2.79 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.87 M | 1.47 M | 4.67 M |
Quarterly Accounts Payables ShockWave Medical
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.84 M | 6.87 M | 12.9 M | 11 M | 6.72 M | 3.47 M | 5.27 M | 8.47 M | 3.52 M | 3.63 M | 2.63 M | 3.73 M | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 2.79 M | 2.79 M | 2.79 M | 2.79 M | 1.49 M | 1.49 M | 1.49 M | 1.49 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 1.47 M | 4.21 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
535 K | $ 2.11 | 8.21 % | $ 3.29 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 10.42 | -1.65 % | $ 1.41 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 12.6 | 2.61 % | $ 1.89 B | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 3.91 | 2.62 % | $ 828 M | ||
|
Cognyte Software Ltd.
CGNT
|
25.2 M | $ 8.38 | -0.24 % | $ 602 M | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 69.79 | 0.95 % | $ 103 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.96 | 1.02 % | $ 148 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 37.41 | 0.35 % | $ 1.16 B | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Cytosorbents Corporation
CTSO
|
3.34 M | $ 0.65 | -8.13 % | $ 35.4 M | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
1.34 M | $ 11.03 | 2.22 % | $ 298 M | ||
|
Establishment Labs Holdings
ESTA
|
43.1 M | $ 63.48 | 0.21 % | $ 1.88 B | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.42 | 0.22 % | $ 121 M | ||
|
InMode Ltd.
INMD
|
17.9 M | $ 13.43 | -0.81 % | $ 868 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
4.24 B | $ 109.95 | 1.8 % | $ 191 B | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.81 | 3.81 % | $ 351 M | ||
|
Bio-Rad Laboratories
BIO
|
122 M | $ 261.24 | -0.59 % | $ 7.37 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.19 | 3.79 % | $ 1.33 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.01 | -2.49 % | $ 694 M | ||
|
AxoGen
AXGN
|
2.89 M | $ 32.84 | 1.55 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
109 M | $ 169.45 | 3.18 % | $ 12.7 B | ||
|
Bruker Corporation
BRKR
|
234 M | $ 32.76 | -2.93 % | $ 4.88 K | ||
|
IRIDEX Corporation
IRIX
|
4.5 M | $ 1.33 | 2.31 % | $ 21.5 M | ||
|
Apyx Medical Corporation
APYX
|
3.06 M | $ 3.67 | 1.1 % | $ 151 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 17.11 | -1.16 % | $ 401 M | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 84.12 | 1.34 % | $ 2.92 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Second Sight Medical Products
EYES
|
817 K | - | -0.97 % | $ 54.4 M |